NOT-MH-18-043: Notice of Extension of the Expiration Date for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)"

Notice of Extension of the Expiration Date for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)"

Notice Number: NOT-MH-18-043

Key Dates
Release Date: August 31, 2018

Related Announcements
RFA-MH-18-702

Issued by
National Institute of Mental Health (NIMH)

Purpose

This Notice extends the expiration date for RFA-MH-18-702, " Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)" for six receipt dates . Due to the extension, the following application due dates will be added, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020 .

Current Expiration Date: October 16, 2018.

New Expiration Date: October 16, 2020.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

For Pediatric Studies

Margaret Grabb, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3563
Email: [email protected]

For Adult Studies

Mi Hillefors, M.D., Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-2738
Email: [email protected]

For Geriatric Studies

Jovier Evans, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-6328
Email: [email protected]